Donate Now
  • What We've Learned
What is the connection between anxiety and other symptoms in rheumatoid arthritis?
ARC_CurrentResearch_Barlett_AnxietyRA_425x296
Scientific Study Title:
Anxiety impacts rheumatoid arthritis symptoms and health-related quality of life even at low levels.
Research Category
Tags
Susan Bartlett, Research Team Member, Arthritis Research Canada
Susan Bartlett
Research Scientist, Medicine, PhD, M-ARP

Why did we do this research?

Reason For Research

Patients with rheumatoid arthritis (RA) have higher levels of anxiety and depression compared to the general population. Depression, in particular, has been linked to increased RA symptoms, such as fatigue, diminished treatment response, and greater disability. Depression and anxiety affect the quality of life for patients living with RA and represent a large gap in patient care.

What did we do?

Execution of Research

We explored the burden of anxiety and depression on health-related quality of life (HRQL) in patients with RA. HRQL is a concept for examining the impact of health on a person’s ability to live a fulfilling life. HRQL includes broad concepts of physical, mental, and social well-being.

Upon enrollment, our participants with RA completed questionnaires to assess depression and anxiety status, as well as HRQL domains, including fatigue, physical function, pain, sleep disturbance, and social participation. We then looked at the association between anxiety and depression with aspects of HRQL.

 

How Can People Get Involved?

Involvement

196 adults with RA participated in our study. As is typical of many RA studies, patients were mainly female, white, with established disease, and two-thirds were in remission or had low disease activity.

 

Media and Infographics

Related Research

What We're Working On Right Now

Exploring a New Immune Cell Therapy for People with Autoimmune Diseases

Systemic sclerosis and systemic lupus erythematosus are serious autoimmune diseases that can cause damage to many organs including the skin, lungs and kidneys. In this project, we will study a new type of treatment that may better control these diseases by targeting the immune cells that cause them. If successful, it could reduce inflammation, slow or stop disease progression, and may even help reset the immune system, so that some patients no longer need long-term immune-suppressing medications.
Read More

Understanding how scleroderma affects people over time

People living with scleroderma experience challenges such as pain, disability, and mental health concerns, but we still don’t know much about how these problems change over time or why some people do better than others. For this research project, our goal is to improve our understanding of how scleroderma affects people’s daily lives and identify factors that may predict changes in their health.
Read More

How can we help Canadians age at home to improve health outcomes and support a sustainable healthcare system?

As Canada’s population ages, home care is important for helping older adults remain safely within their homes. Our research team is linking data from the Canadian Longitudinal Study on Aging with health records in British Columbia, Ontario, and New Brunswick, to track patterns of paid and unpaid home care use over time.
Read More